These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1208758)

  • 41. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
    Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA
    Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of the behavioral effects of DOM homologs.
    Glennon RA; Young R; Rosecrans JA
    Pharmacol Biochem Behav; 1982 Apr; 16(4):557-9. PubMed ID: 7071089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD.
    Palumbo PA; Winter JC
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1221-6. PubMed ID: 1475306
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of some phenylethylamines in rhesus monkeys trained to discriminate (+)-amphetamine from saline.
    Woolverton WL; English JA
    Drug Alcohol Depend; 1997 Mar; 44(2-3):79-85. PubMed ID: 9088779
    [TBL] [Abstract][Full Text] [Related]  

  • 45. alpha-Ethyltryptamine (alpha-ET) as a discriminative stimulus in rats.
    Glennon RA; Bondareva T; Young R
    Pharmacol Biochem Behav; 2006 Oct; 85(2):448-53. PubMed ID: 17112572
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discriminative stimulus properties of the hallucinogenic agent DOM.
    Young R; Glennon RA; Rosecrans JA
    Commun Psychopharmacol; 1980; 4(6):501-6. PubMed ID: 7297054
    [No Abstract]   [Full Text] [Related]  

  • 47. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
    Glennon RA; Young R; Rosecrans JA
    Eur J Pharmacol; 1983 Jul; 91(2-3):189-96. PubMed ID: 6617740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stereospecific actions of 2,5-dimethoxy-4-methylamphetamine (DOM) on colonic temperature in the rat at various ambient temperatures.
    Beaton JM; Benington F; Bradley RJ; Kuhlemeier KV; Morin RD
    Br J Pharmacol; 1976 Aug; 57(4):547-50. PubMed ID: 134754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of behavioral effects of cathinone, amphetamine and apomorphine.
    Schechter MD; Rosecrans JA; Glennon RA
    Pharmacol Biochem Behav; 1984 Feb; 20(2):181-4. PubMed ID: 6718445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug discrimination in rats: evidence for amphetamine-like cue state following chronic haloperidol.
    Barrett RJ; Steranka LR
    Pharmacol Biochem Behav; 1983 Apr; 18(4):611-7. PubMed ID: 6867066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stimulus properties of ring-methyl amphetamine analogs.
    Higgs RA; Glennon RA
    Pharmacol Biochem Behav; 1990 Dec; 37(4):835-7. PubMed ID: 2093186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CGS 10746B is able to attenuate the effects of amphetamine: further evidence for dopaminergic mediation.
    Schechter MD; Boja JW
    Pharmacol Biochem Behav; 1988 Aug; 30(4):1089-92. PubMed ID: 2906435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans.
    Heishman SJ; Henningfield JE
    Psychopharmacology (Berl); 1991; 103(4):436-42. PubMed ID: 2062984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the effects of 2,5-dimethoxy-4-iodoamphetamine and D-amphetamine on the ability of rats to discriminate the durations and intensities of light stimuli.
    Hampson CL; Body S; den Boon FS; Cheung TH; Bezzina G; Langley RW; Fone KC; Bradshaw CM; Szabadi E
    Behav Pharmacol; 2010 Feb; 21(1):11-20. PubMed ID: 19949322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimulus control and the effects of d-amphetamine in the rat.
    Laties VG; Wood RW; Rees DC
    Psychopharmacology (Berl); 1981; 75(3):277-82. PubMed ID: 6798618
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Paroxetine, a selective 5-hydroxytryptamine uptake inhibitor with antidepressant properties, lacks amphetamine-like stimulus properties in an operant drug discrimination bioassay in rodents.
    Goudie AJ; Dubicki W; Leathley M
    J Pharm Pharmacol; 1988 Mar; 40(3):192-6. PubMed ID: 2899149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discriminative properties of the psychostimulant dl-cathinone in a two lever operant task. Lack of evidence for dopaminergic mediation.
    Goudie AJ; Atkinson J; West CR
    Neuropharmacology; 1986 Jan; 25(1):85-94. PubMed ID: 2869439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A preliminary investigation of the psychoactive agent 4-bromo-2,5-dimethoxyphenethylamine: a potential drug of abuse.
    Glennon RA; Titeler M; Lyon RA
    Pharmacol Biochem Behav; 1988 Jul; 30(3):597-601. PubMed ID: 3211969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.
    Gatch MB; Dolan SB; Forster MJ
    Behav Pharmacol; 2017 Aug; 28(5):375-385. PubMed ID: 28537942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interactions of clozapine with the stimulus effects of DOM and LSD.
    Palumbo PA; Winter JC
    Pharmacol Biochem Behav; 1994 Sep; 49(1):115-20. PubMed ID: 7816860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.